Neuraxis NRXS
NYSE NRXS
$5.50 -0.25 (-4.35%)
At close: Nov 13, 2026 · 4:00 PM EST

Neuraxis (NRXS) Other financing activities (as filed) (2025 - 2026)

Updated

Neuraxis' Other financing activities (as filed) came in at -$335,213 for Q3 2026, compared with -$113,617 a year earlier.

Analysis

Neuraxis (NRXS) Other financing activities (as filed) (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Neuraxis reported Other financing activities (as filed) of -$373,479; for FY2025, it came in at -$712,669.

  • Going back by year, Other financing activities (as filed) was -$194,502 in FY2024, -$552,000 in FY2023 and -$866,736 in FY2022.
  • Business Quant data shows NRXS's Other financing activities (as filed) at $94,003 (Q2 2026), $6,784 (Q1 2026) and -$139,053 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Neuraxis 75.94 Mn 51.10 Mn 1.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -335,213.00
Jun 30, 2026 94,003.00
Mar 31, 2026 6,784.00
Dec 31, 2025 -139,053.00
Sep 30, 2025 -113,617.00
API Access

Neuraxis Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=NRXS&period=max&api_key=YOUR_API_KEY